Is there a public exploit for CVE-2020-1002?

No public exploit for CVE-2020-1002 was found in Exploit-DB, Metasploit, Nuclei templates or public proof-of-concept repositories. That is an absence of evidence rather than proof that none exists.

What does CVE-2020-1002 affect?

CVE-2020-1002 affects Microsoft Windows Defender on Windows Server 2012 R2, Windows Defender on Windows 10 Version 1607 for x64-based Systems, Windows Defender on Windows Server 2012 R2 (Server Core installation), Windows Defender on Windows 10 Version 1709 for 32-bit Systems, Windows Defender on Windows Server 2008 R2 for x64-based Systems, Windows Defender on Windows 10 Version 1809 for ARM64-based Systems.

— Unscored

An elevation of privilege vulnerability exists when the MpSigStub.exe for Defender allows file deletion in arbitrary locations.To exploit…

CVE-2020-1002

An elevation of privilege vulnerability exists when the MpSigStub.exe for Defender allows file deletion in arbitrary locations.To exploit the vulnerability, an attacker would first have to log on to the system, aka 'Microsoft Defender Elevation of Privilege Vulnerability'.

Assessment

CVSS: Not yet scored
Severity: Unscored
EPSS: 0.71% chance of exploitation in the next 30 days
Known exploited: Not listed in CISA KEV
Exploit availability: Nothing found in Exploit-DB, Metasploit, Nuclei or public PoC repositories
Published: 15 April 2020
Last updated: 2 November 2026
Affected: Microsoft · Microsoft Forefront Endpoint Protection · Microsoft Security Essentials · Microsoft System Center · Windows Defender on Windows 10 Version 1607 for 32-bit Systems
Assigner: microsoft

At the source

EUVD (ENISA)

References

https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2020-1002

Community proofs of concept

No community proof of concept yet. If you have one for a published vulnerability and the right to share it, add it below — it will appear here once reviewed.

Submit a proof of concept

Only for publicly disclosed vulnerabilities, and only material from testing you were authorised to perform. This platform does not buy, sell, or broker exploits — see earning from vulnerability research for legitimate bounty programs. Submissions are reviewed before they appear. Text only; do not include live credentials, personal data, or anything targeting systems you are not permitted to test.

Title *

Proof of concept *

Write-up (optional)

Affected versions (optional)

Name or handle (optional)

References (optional, one URL per line)

Licence for your contribution *

Private contact (optional, never shown)

Before you submit * This vulnerability is already publicly disclosed (it has a published CVE). This material comes only from testing I was authorised to perform. I have the legal right to publish this content and am not breaching any agreement by doing so. It contains no live credentials, personal data, or anything targeting systems I am not authorised to test. I understand it will be reviewed before it appears publicly and may be rejected. I agree to the submission terms.

What is 4 + 7? *

Query this programmatically

Agents can read this through the MCP endpoint, or over HTTP:

curl https://cve.zerocrew.in/api/cve/CVE-2020-1002